Latest Breaking News On - Company or sequanamedical - Page 6 : comparemela.com

Sequana Medical NV: Transparency Notifications from Shareholders

Sequana Medical NV: Transparency Notifications from Shareholders
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesFederale participatieCompany or sequanamedicalBelfius banque sa bankBelgian financial servicesBelfius bankEuronext brusselsBelfius insuranceBelfius banqueDexia banqueBelgian stateBelgian actSequana medicalBelgian transparency actMarkets authorityPre market approval

Transparency Notifications from Shareholders

PRESS RELEASEREGULATED INFORMATION15 January 2024, 06:00 pm CETGhent, Belgium – 15 January 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (t.

United statesFederale participatieBelfius bankBelfius banque sa bankCompany or sequanamedicalBelgian financial servicesSequana medicalEuronext brusselsBelfius insuranceBelfius banqueDexia banqueBelgian stateBelgian actBelgian transparency actMarkets authorityPre market approval

Sequana Medical NV: Sequana Medical submits Premarket Approval application to US FDA for alfapump® in recurrent or refractory ascites due to liver cirrhosis

Sequana Medical NV: Sequana Medical submits Premarket Approval application to US FDA for alfapump® in recurrent or refractory ascites due to liver cirrhosis
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesTimur reschCian crosbieStefan klotterCompany or sequanamedicalHealth solutionsDrug administrationEuronext brusselsPremarket approvalGlobal vice presidentSequana medicalChief executive officerNorth americanPivotal cohortMajor adverse eventsNorth american consortium

Sequana Medical submits Premarket Approval application to US FDA for alfapump® in recurrent or refractory ascites due to liver cirrhosis

Sequana Medical submits Premarket Approval application to US FDA for alfapump® in recurrent or refractory ascites due to liver cirrhosis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesTimur reschCian crosbieHealth solutionsDrug administrationCompany or sequanamedicalSequana medicalEuronext brusselsPremarket approvalGlobal vice presidentChief executive officerNorth americanPivotal cohortMajor adverse eventsNorth american consortiumEnd stage liver

Sequana Medical NV: Sequana Medical announces positive data from non-randomized cohort in US Phase 1/2a MOJAVE study of DSR® 2 0 for treatment of heart failure

Sequana Medical NV: Sequana Medical announces positive data from non-randomized cohort in US Phase 1/2a MOJAVE study of DSR® 2 0 for treatment of heart failure
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesStefan klotterYork heart associationCompany or sequanamedicalEuronext brusselsChief medical officerSequana medicalSafety monitoring boardNew york heart associationSeattle heart failureNorth americanPre market approvalData safety monitoringGlomerular filtration rateLassen sie